CIK 0001593899
- Non-accelerated filer
- Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 460574869
- Phone
- +1 857-284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $319,804
- in 3 filings
Net −$319,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Exercise or conversion | +58,050 | 141,801 | ||
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Shares withheld for taxes | −14,136 | $4.24 | $60K | 127,665 |
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Exercise or conversion · Restricted Stock Units | −46,800 | 0 | ||
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Exercise or conversion · Restricted Stock Units | −11,250 | 0 | ||
| 2026-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +177,000 | 177,000 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Exercise or conversion | +46,800 | 84,272 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award | +11,250 | 95,522 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Shares withheld for taxes | −14,134 | $3.06 | $43K | 81,388 |
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Exercise or conversion · Restricted Stock Units | −46,800 | 46,800 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Restricted Stock Units | +11,250 | 11,250 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-02-01 | Hammond Janet MJ Chief Development Officer | Sale | −14,029 | $3.84 | $54K | 35,362 |
| 2024-01-31 | Hammond Janet MJ Chief Development Officer | Exercise or conversion | +46,800 | 49,391 | ||
| 2024-01-31 | Hammond Janet MJ Chief Development Officer | Exercise or conversion · Restricted Stock Units | −46,800 | 93,600 | ||
| 2024-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +225,200 | 225,200 | ||
| 2023-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Restricted Stock Units | +140,400 | 140,400 | ||
| 2023-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +196,600 | 196,600 | ||
| 2022-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2021-01-29 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +160,050 | 160,050 |
Page 1 of 1 · 19 trades